Indication
Temporomandibular Disorder
10 clinical trials
21 products
Clinical trial
Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction (A Randomized Clinical Trial)Status: Completed, Estimated PCD: 2021-04-01
Product
Hypertonic DextroseClinical trial
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate TreatmentsStatus: Completed, Estimated PCD: 2024-03-13
Product
NortriptylineProduct
Placebo creamProduct
PlaceboClinical trial
Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular DisorderStatus: Completed, Estimated PCD: 2021-09-01
Product
ECa 233Product
IbuprofenClinical trial
Assessment of the Effectiveness of Intra-articular Injectable Platelet-rich Fibrin (iPRF) Injections in the Management of Mild and Moderate Degeneration of the Temporomandibular JointsStatus: , Estimated PCD: 2024-12-31
Product
Platelet-rich plasmaClinical trial
Evaluation of the Quality of Sleep, Endothelial Function, Cardiovascular Risk, Thyroid Function, a Function of Masticatory Muscles and Psycho-emotional State of Patients With Sleep BruxismStatus: , Estimated PCD: 2024-12-01
Product
OpipramolClinical trial
Neural Mechanisms of Immersive Virtual Reality in Chronic PainStatus: Recruiting, Estimated PCD: 2027-10-31
Product
NaloxoneClinical trial
Evaluation of the Efficacy of Different Drugs in the Treatment of the Pain in Patients With Temporomandibular DisorderStatus: Completed, Estimated PCD: 2021-07-15
Product
Dexketoprofen TrometamolProduct
ParacetamolClinical trial
Assesment of ODF ( Oral Dissolvable Film) With Long-term CBD Release in the Treatment of Temporomandibular DisordersStatus: Recruiting, Estimated PCD: 2023-07-30
Product
5% polymer gel with CBDProduct
Polymer gel with CBDClinical trial
A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients With Temporomandibular DisorderStatus: Completed, Estimated PCD: 2024-01-04
Product
Erenumab-aooeClinical trial
Comparison of Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles in the Management of Myofascial Pain Disorder: A Randomized Clinical TrialStatus: Completed, Estimated PCD: 2020-03-13
Product
Botulinum toxin type AProduct
0.9% Sodium Chloride